Research ArticleOncology
Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P. Rowe, Xin Li, Bruce J. Trock, Rudolf A. Werner, Sarah Frey, Michael DiGianvittorio, J. Keith Bleiler, Diane K. Reyes, Rehab Abdallah, Kenneth J. Pienta, Michael A. Gorin and Martin G. Pomper
Journal of Nuclear Medicine February 2020, 61 (2) 183-188; DOI: https://doi.org/10.2967/jnumed.119.227793
Steven P. Rowe
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Xin Li
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
3Department of Radiology, Shandong Provincial Hospital, Shandong University, Jinan City, Shandong Province, China
Bruce J. Trock
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Rudolf A. Werner
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
4Department of Nuclear Medicine, University Hospital Wurzburg, Wurzburg, Germany
Sarah Frey
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
Michael DiGianvittorio
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
5Spectrum Medical Group, South Portland, Maine; and
J. Keith Bleiler
6Greater Boston Urology, Dedham, Massachusetts
Diane K. Reyes
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Rehab Abdallah
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
Kenneth J. Pienta
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Michael A. Gorin
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Martin G. Pomper
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
2James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 2
February 1, 2020
Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P. Rowe, Xin Li, Bruce J. Trock, Rudolf A. Werner, Sarah Frey, Michael DiGianvittorio, J. Keith Bleiler, Diane K. Reyes, Rehab Abdallah, Kenneth J. Pienta, Michael A. Gorin, Martin G. Pomper
Journal of Nuclear Medicine Feb 2020, 61 (2) 183-188; DOI: 10.2967/jnumed.119.227793
Prospective Comparison of PET Imaging with PSMA-Targeted 18F-DCFPyL Versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P. Rowe, Xin Li, Bruce J. Trock, Rudolf A. Werner, Sarah Frey, Michael DiGianvittorio, J. Keith Bleiler, Diane K. Reyes, Rehab Abdallah, Kenneth J. Pienta, Michael A. Gorin, Martin G. Pomper
Journal of Nuclear Medicine Feb 2020, 61 (2) 183-188; DOI: 10.2967/jnumed.119.227793
Jump to section
Related Articles
Cited By...
- Prospective Head-to-Head Comparison of 18F-PSMA PET/CT and 18F-NaF PET/CT for Assessing Bone Metastases in 160 Patients with Newly Diagnosed High-Risk Prostate Cancer
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
- Molecular Imaging of Bone Metastases and Their Response to Therapy